G. Koumakis

1.1k total citations
21 papers, 149 citations indexed

About

G. Koumakis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, G. Koumakis has authored 21 papers receiving a total of 149 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in G. Koumakis's work include Cancer Treatment and Pharmacology (10 papers), Advanced Breast Cancer Therapies (8 papers) and HER2/EGFR in Cancer Research (4 papers). G. Koumakis is often cited by papers focused on Cancer Treatment and Pharmacology (10 papers), Advanced Breast Cancer Therapies (8 papers) and HER2/EGFR in Cancer Research (4 papers). G. Koumakis collaborates with scholars based in Greece, Cyprus and India. G. Koumakis's co-authors include V. Barbounis, Anna Efremidis, M. Vassilomanolakis, George Orphanos, S. Tsousis, Vasiliki Rapti, Georgia Kourlaba, A. Alexopoulos, Nikolaos Tsoukalas and Alexandros Ardavanis and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

G. Koumakis

20 papers receiving 143 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Koumakis Greece	7	94	37	27	25	24	21	149
Mahmoud Al-Masri Jordan	7	63 0.7×	78 2.1×	19 0.7×	31 1.2×	25 1.0×	23	148
Carole Massabeau France	9	68 0.7×	78 2.1×	56 2.1×	28 1.1×	14 0.6×	32	196
Suchitra Sundaram United States	7	54 0.6×	19 0.5×	22 0.8×	11 0.4×	13 0.5×	25	148
Sarah Bétrian France	9	59 0.6×	18 0.5×	26 1.0×	53 2.1×	21 0.9×	25	173
H. Njimi Belgium	5	95 1.0×	62 1.7×	30 1.1×	21 0.8×	40 1.7×	6	163
J. Selleslags Belgium	6	194 2.1×	72 1.9×	64 2.4×	34 1.4×	38 1.6×	7	243
Marinella Mistrangelo Italy	6	103 1.1×	64 1.7×	70 2.6×	54 2.2×	24 1.0×	11	161
Eleonora Mioranza Italy	7	74 0.8×	62 1.7×	40 1.5×	20 0.8×	22 0.9×	15	133
Koichi Takayama Japan	6	58 0.6×	31 0.8×	33 1.2×	15 0.6×	4 0.2×	18	166
Benjamin Thoreau France	8	30 0.3×	9 0.2×	47 1.7×	20 0.8×	28 1.2×	23	190

Countries citing papers authored by G. Koumakis

Since Specialization

Citations

This map shows the geographic impact of G. Koumakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Koumakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Koumakis more than expected).

Fields of papers citing papers by G. Koumakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Koumakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Koumakis. The network helps show where G. Koumakis may publish in the future.

Co-authorship network of co-authors of G. Koumakis

This figure shows the co-authorship network connecting the top 25 collaborators of G. Koumakis. A scholar is included among the top collaborators of G. Koumakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Koumakis. G. Koumakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alexopoulos, A., Charisios Karanikiotis, Alexandros Ardavanis, et al.. (2022). Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI” study). Anticancer Research. 42(2). 1031–1041. 4 indexed citations

Koutras, Αngelos, Flora Zagouri, Georgia-Angeliki Koliou, et al.. (2020). Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes—a Hellenic Cooperative Oncology Group (HeCOG) Trial. British Journal of Cancer. 123(3). 355–361. 11 indexed citations

Kotsakis, Αthanasios, Alexandros Ardavanis, G. Koumakis, et al.. (2019). Epidemiological characteristics, clinical outcomes and management patterns of metastatic breast cancer patients in routine clinical care settings of Greece: Results from the EMERGE multicenter retrospective chart review study. BMC Cancer. 19(1). 88–88. 3 indexed citations

Fountzilas, Elena, Georgia-Angeliki Koliou, Vasiliki Rapti, et al.. (2019). Clinical outcome and toxicity data in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy in a real-world clinical setting. Annals of Oncology. 30. v118–v118. 1 indexed citations

Kourlaba, Georgia, Vasiliki Rapti, A. Alexopoulos, et al.. (2015). Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation study. BMC Health Services Research. 15(1). 307–307. 10 indexed citations

Tsoukalas, Nikolaos, Maria Tolia, Evangelos Bournakis, et al.. (2014). Risk factors, pathological and phenotypic features of male breast cancer in Greece.. PubMed. 34(3). 1291–4. 1 indexed citations

Skoura, Evangelia, et al.. (2014). (18)F-FDG-PET/CT, (123)I-MIBG and (99m)Tc-MDP whole-body scans, in detecting recurrence of an adult adrenal neuroblastoma.. PubMed. 17(1). 58–61. 1 indexed citations

Tsoukalas, Nikolaos, Ioannis D. Kostakis, Maria Tolia, et al.. (2014). A collecting duct carcinoma producing carcinoembryonic antigen and Ca-125 in a 29-year-old woman. International Urology and Nephrology. 46(7). 1313–1316.

Kourlaba, Georgia, Vasiliki Rapti, A. Alexopoulos, et al.. (2014). Economic evaluation of everolimus plus exemestane versus bevacizumab plus paclitaxel and bevacizumab plus capecitabine for the management of postmenopausal women with ER+ breast cancer.. Journal of Clinical Oncology. 32(15_suppl). e17638–e17638. 1 indexed citations

10.

Kourlaba, Georgia, Vasiliki Rapti, A. Alexopoulos, et al.. (2014). Cost Effectiveness Analysis of Everolimus Plus Exemestane Vs. Bevacizumab Plus Paclitaxel and Bevacizumab Plus Capecitabine for the Management of Postmenopausal Women with Er+ Breast Cancer. Annals of Oncology. 25. iv117–iv117. 1 indexed citations

11.

Tsoukalas, Nikolaos, et al.. (2013). Complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedin. Oncology Letters. 7(1). 47–49. 5 indexed citations

12.

Kostakis, Ioannis D., et al.. (2013). Neoplastic pericarditis as the initial manifestation of a papillary thyroid carcinoma. Upsala Journal of Medical Sciences. 118(3). 196–198. 4 indexed citations

13.

Koumakis, G., et al.. (2013). Dermatomyositis as an early manifestation and a significant clinical precursor of lung cancer: report of a rare case and review of the current literature.. PubMed. 6(2). 105–9. 10 indexed citations

14.

Tsoukalas, Nikolaos, et al.. (2013). Coexistence of intracranial germ cell tumor and craniopharyngioma in an adolescent: case report and review of the literature.. PubMed. 6(3). 211–8. 6 indexed citations

15.

Papadimitriou, Konstantinos, et al.. (2009). Relationship between lymphovascular invasion (LVI) and prognostic markers in different subtypes of breast cancer. Journal of Clinical Oncology. 27(15_suppl). e22109–e22109. 1 indexed citations

16.

Vassilomanolakis, M., et al.. (2003). Vinorelbine and Cisplatin for Metastatic Breast Cancer: A Salvage Regimen in Patients Progressing After Docetaxel and Anthracycline Treatment. Cancer Investigation. 21(4). 497–504. 26 indexed citations

17.

Vassilomanolakis, M., G. Koumakis, V. Barbounis, George Orphanos, & Anna Efremidis. (2001). Prevention of vinorelbine phlebitis with cimetidine. Supportive Care in Cancer. 9(2). 108–111. 19 indexed citations

18.

Vassilomanolakis, M., et al.. (2000). Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines. Annals of Oncology. 11(9). 1155–1160. 30 indexed citations

19.

Barbounis, V., et al.. (1995). A phase II study of ondansetron as antiemetic prophylaxis in patients receiving high-dose polychemotherapy and stem cell transplantation. Supportive Care in Cancer. 3(5). 301–306. 13 indexed citations

20.

Koumakis, G., et al.. (1995). Relation Between Hematological Recovery and Number of Transplanted Mononuclear Cells in Patients after High Dose Chemotherapy with Peripheral Blood Stem Cell (PBSC) Rescue. Blood Cells Molecules and Diseases. 21(3). 235–238. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact